-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-section-2-tables-1-5.pdf
June 02, 2025 - 747.40, 747.41, 747.42, 747.49
Chromosomes 758.3, 758.5, 758.89, 758.9, 759.4, 759.7, 759.89, 759.9
Central … Nervous System 741.00, 741.01, 741.02, 741.03, 741.90, 741.91, 741.92, 741.93, 742.0, 742.1, 742.2,
-
www.ahrq.gov/patient-safety/reports/liability/neumiller.html
August 01, 2017 - categories of medicines implicated in ADEs requiring an ED visit included the following broad classes: (1) central … nervous system agents (including opioids); (2) systemic antimicrobial agents; (3) hormone modifying
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/French.pdf
April 27, 2004 - Effects of
central nervous system polypharmacy on falls liability
in community dwelling elderly.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket.pdf
December 01, 2013 - ■ Better nervous system development and higher IQ
levels. … ■ Types of apnea:
– Central: the respiratory center in the immature brain stem does not trigger … ■ Methylxanthines: act primarily on the brainstem respiratory structures, producing a central
stimulatory … – May have a functional role in stimulating the nervous system, encouraging growth and
maturation … In Kelly (2006), adapted from Verma, Sridhar, and Spitzer (2003)
© 2003 Fenton; licensee BioMed Central
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/settings/hospitals/nicupacket.pdf
December 01, 2013 - ■ Better nervous system development and higher IQ
levels. … ■ Types of apnea:
– Central: the respiratory center in the immature brain stem does not trigger … ■ Methylxanthines: act primarily on the brainstem respiratory structures, producing a central
stimulatory … – May have a functional role in stimulating the nervous system, encouraging growth and
maturation … Kelly (2006), adapted from Verma, Sridhar, and Spitzer (2003)
© 2003 Fenton; licensee BioMed Central
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Duthie.pdf
January 01, 2004 - cardiovascular drugs and narcotic analgesics, both at
14 percent; anticoagulants at 11 percent; followed by central … nervous system
(CNS) medications and antibiotics, both at 8 percent.
-
www.ahrq.gov/es/patient-safety/settings/hospital/resource/nicu/packet/apb2.html
December 01, 2013 - May have a functional role in stimulating the nervous system, encouraging growth and maturation. … Fetal-Infant Growth Chart for Preterm Infants
©2003 Fenton; licensee BioMed Central Ltd.
-
www.ahrq.gov/patient-safety/settings/hospital/resource/nicu/packet/apb2.html
December 01, 2013 - May have a functional role in stimulating the nervous system, encouraging growth and maturation. … Fetal-Infant Growth Chart for Preterm Infants
©2003 Fenton; licensee BioMed Central Ltd.
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa/043-vap-prevention-notes.docx
October 01, 2024 - Patients who are taking central nervous system depressants are at a higher risk for aspiration.
-
www.ahrq.gov/sites/default/files/2024-01/bates-report.pdf
January 01, 2024 - psychotropic medications most commonly associated with ADEs were
atypical antipsychotics, and the central … nervous system was the most frequently affected
organ system. … In most healthcare settings, the
providers are the central, ongoing components of the system of care
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb.pdf
June 02, 2025 - ■ Types of apnea:
– Central: the respiratory center in the immature brain stem does not trigger … ■ Methylxanthines: act primarily on the brainstem respiratory structures, producing a central
stimulatory … – May have a functional role in stimulating the nervous system, encouraging growth and
maturation … In Kelly (2006), adapted from Verma, Sridhar, and Spitzer (2003)
© 2003 Fenton; licensee BioMed Central
-
www.ahrq.gov/hai/cauti-tools/archived-webinars/leveraging-cultural-change-transcript.html
December 01, 2017 - Central Time. Excuse me, everyone. We now have all of our speakers in conference. … And oftentimes, it's really influences by the involuntary nervous system. … discrepancy is, that oftentimes physicians feel that it's just inappropriate, it's the involuntary nervous
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/leveraging-cultural-change-transcript.doc
August 12, 2014 - Central Time. Excuse me, everyone. We now have all of our speakers in conference. … And oftentimes, it’s really influences by the involuntary nervous system. … discrepancy is, that oftentimes physicians feel that it’s just inappropriate, it’s the involuntary nervous
-
www.ahrq.gov/sites/default/files/wysiwyg/diagnostic/resources/issue-briefs/dx-safety-patient-role.pdf
September 01, 2024 - clinicians without patient input, focusing mainly on research.43 The patient’s
voice was not always central … Thus, enhancing communication between patients and their healthcare
team is central to improving diagnostic … Forum on Microbial Threats and Forum on Neuroscience and Nervous System Disorders.
-
www.ahrq.gov/sites/default/files/wysiwyg/diagnostic/dx-safety-issue-brief-co-design-rev.pdf
September 01, 2024 - clinicians without patient input, focusing mainly on research.43 The patient’s
voice was not always central … Thus, enhancing communication between patients and their healthcare
team is central to improving diagnostic … Forum on Microbial Threats and Forum on Neuroscience and Nervous System Disorders.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0198-fullreport.pdf
November 01, 2019 - These
complications include compromised airway, hypoxia leading to central nervous system (CNS)
injury … geographically
diverse Blue Cross Blue Shield (BCBS) health plans in the Northeast, South, West, and Central
-
www.ahrq.gov/sites/default/files/2024-01/lo-report.pdf
January 01, 2024 - hepatic encephalopathy plus encephalopathy treatment (e.g., lactulose or rifaximin) with no
other central … nervous system abnormality or 2) liver transplant due to an unspecified etiology. … Descriptive epidemiology of acute liver enzyme
abnormalities in the general population of central Massachusetts
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/fielding-cancer-53.pdf
July 14, 2017 - nervous system
C73-C75 Thyroid and other endocrine glands
C4A, C7A Neuroendocrine tumors
C76 … Maintaining Confidentiality
Privacy assurances are central to encouraging respondent participation. … portion of right female breast
C50.112 Malignant neoplasm of central portion of left female breast … C50.122 Malignant neoplasm of central portion of left male breast
C50.129 Malignant neoplasm of … central portion of unspecified male breast
C50.211 Malignant neoplasm of upper-inner quadrant of right
-
www.ahrq.gov/sites/default/files/publications2/files/dx-safety-21-diagnostic-stewardship.pdf
August 01, 2024 - roles in both antimicrobial stewardship72 and diagnostic
stewardship, but their contributions are central … Clinical and financial impact of a diagnostic stewardship program for children with suspected central … nervous system infection.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-209-section-1-tables.pdf
June 02, 2025 - 747.40, 747.41, 747.42, 747.49
Chromosomes 758.3, 758.5, 758.89, 758.9, 759.4, 759.7, 759.89, 759.9
Central … Nervous System 741.00, 741.01, 741.02, 741.03, 741.90, 741.91, 741.92, 741.93, 742.0, 742.1, 742.2,